Cetera Trust Company’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.82M Sell
17,568
-125
-0.7% -$11.2K 0.91% 29
2026
Q1
$1.27M Buy
17,693
+2,575
+17% +$198K 0.72% 38
2025
Q4
$1.2M Buy
15,118
+2,525
+20% +$199K 0.64% 40
2025
Q3
$949K Buy
12,593
+325
+3% +$22.3K 0.53% 48
2025
Q2
$846K Buy
12,268
+725
+6% +$47.5K 0.51% 49
2025
Q1
$782K Buy
11,543
+3,625
+46% +$217K 0.5% 50
2024
Q4
$355K Sell
7,918
-9,125
-54% -$512K 0.23% 78
2024
Q3
$1.07M Sell
17,043
-1,190
-7% -$69.4K 0.66% 39
2024
Q2
$1.08M Sell
18,233
-1,510
-8% -$94.5K 0.68% 39
2024
Q1
$1.57M Buy
19,743
+400
+2% +$30.6K 0.95% 35
2023
Q4
$1.53M Buy
+19,343
New +$1.38M 0.95% 34

Other funds holding CVS

Cetera Trust Company's CVS Position: Q2 2026 in Review

Cetera Trust Company reduced its CVS Health (CVS) stake by 0.71% in Q2 2026, selling an estimated $11.2K and leaving 17,568 shares worth $1.82M. The position accounts for 0.91% of the portfolio, ranked #29.

Cetera Trust Company first reported a position in CVS in Q4 2023 and has held it in 11 quarters since. 2,069 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Cetera Trust Company held 17,568 shares of CVS Health worth $1.82M as of Q2 2026.
  • Cetera Trust Company sold 125 CVS Health shares in Q2 2026, an estimated $11.2K.
  • CVS Health made up 0.91% of Cetera Trust Company's portfolio in Q2 2026, its #29 holding.
  • Cetera Trust Company first reported a position in CVS Health in Q4 2023 and has held it in 11 quarters since.
  • 2,069 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Cetera Trust Company's 13F filing for Q2 2026, filed 13 Aug 2026.